Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan and PDL for Resistant Port-wine Stains
NCT02317679Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Apr 2014
- Primary completion
- Sep 2014
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in port-wine stain, sponsored by Centre Hospitalier Universitaire de Nice. Started Apr 2014; status: completed.
02
Drugs
bosentan
03
Conditions
port-wine stain
Beyond the preview
Go deeper on NCT02317679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317679.